Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Pulmotect initiates phase II study of PUL-042

Jan. 17, 2019

Knopp Biosciences expands dexpramipexole research collaboration with Cincinnati Children's Hospital

Jan. 16, 2019

Verona reports topline data from 3-day phase II study of ensifentrine for COPD

Jan. 14, 2019

Design and synthesis of novel imidazole-biaryl-tetrazole-based GSNOR inhibitors for COPD

Jan. 11, 2019

PTMs affect, as well as are affected by, protein folding

Jan. 8, 2019

First cohort dosed in phase I study of PLN-74809

Jan. 4, 2019

Institute of Materia Medica of Beijing presents compounds for cough

Jan. 3, 2019

Eloxx Pharmaceuticals synthesizes compounds for genetic disorders

Jan. 3, 2019

Chiesi Farmaceutici patents new MAPK 14 inhibitors

Jan. 2, 2019

SRS-143 demonstrates promising results in preclinical models of asthma

Dec. 28, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...